Binding to and responding, e.g. by conformational change, to changes in the cellular level of an amino acid.

Binding to and responding, e.g. by conformational change, to changes in the cellular level of tyrosine.

Binding to 2-amino-3-(4-hydroxyphenyl)propanoic acid.

Binding to a protein serine/threonine kinase.

The volume that is enclosed within the autolysosome single-membrane.

A lipid bilayer that surrounds an autolysosome, a single-membrane-bounded vesicle in which endogenous cellular material is degraded.

The cilary pro-basal body is an immature, partially assembled form of a ciliary basal body found next to the basal body of a cilium. Pro-basal bodies are not capable of nucleating a cilium. As the cell progresses through the cell cycle, continuing assembly will convert the pro-basal body into a mature basal body that is capable of nucleating a cilium.

Any process that modulates the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet aggregation inhibitor stimulus.

The acetylation of peptidyl-threonine to form peptidyl-O-acetyl-L-threonine.

OBSOLETE. Any positive regulation of cyclin-dependent protein serine/threonine kinase activity that is involved in positive regulation of G2/M transition of mitotic cell cycle.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aromatase inhibitor stimulus.

Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an anticoagulant stimulus.

Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.

The process of coupling valine to valyl-tRNA in the cytosol, catalyzed by valyl-tRNA synthetase. In tRNA aminoacylation, the amino acid is first activated by linkage to AMP and then transferred to either the 2'- or the 3'-hydroxyl group of the 3'-adenosine residue of the tRNA.

Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.

Any process that modulates the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.

Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reverse transcriptase inhibitor stimulus.